1-30 31-60 61-90 91-120 121-150 151-180 181-210 211-240 241-270 271-300 301-330 331-360 361-390 391-420 421-450 451-480 481-510 511-540 541-570 571-600 601-630 631-660 661-690 691-720 721-750 751-780 781-810 811-840 841-870 871-900 901-930 931-960 961-973

NICE backs Merck KGaA’s Erbitux in head/neck cancers| 07 May 08

The National Institute for Health and Clinical Excellence has issued a Final Appraisal Determination recommending the use of Merck KGaA’s Erbitux (cetuximab) in combination with radiotherapy for the treatment of locally-advanced head and neck cancer in National Health Service patients in England and Wales who are contraindicated to all forms of platinum based chemoradiotherapy.

• View article as featured on pharmatimes.com

Keyboards harbour harmful bacteria, Which? Computing tests reveal bugs| 06 May 08

Roche to fight NICE’s rejection of Tarceva| 30 Apr 08

GE Healthcare Completes Acquisition Of Whatman Plc| 29 Apr 08

Deadly Dose: Heparin Expert Helps Uncover Source Of Lethal Contamination| 28 Apr 08

NICE scientific advice "could disadvantage smaller drug firms" | 25 Apr 08

Threat To Pharmaceutical Industry Support For University Research| 24 Apr 08

Boehringer Ingelheim launches Pradaxa in the UK | 23 Apr 08

Genentech's cancer drug increases lung cancer survival | 22 Apr 08

UK’s Shire switches to Ireland for tax reasons | 21 Apr 08

Walmark establishes office in Paris | 18 Apr 08

UK appeal against NICE Alzheimer’s decision process begins | 17 Apr 08

Asthmatics - don't waste your money.| 16 Apr 08

Marshall Edwards's tiphendiol shows potent activity against biliary cancers | 15 Apr 08

GlaxoSmithKline Confirms Receipt Of US FDA Letter On Regulatory Reporting| 14 Apr 08

Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, To Combat Hospital And Community Acquired Superbug Infections, Including MRSA| 11 Apr 08

Published Study Documents Biologic Potential Of Cellular Compositions From Harvest Technologies' BMAC System(TM)| 10 Apr 08

Pfizer to establish Middle East headquarters in Dubai| 08 Apr 08

NICE: still “tallest kid in playground,” but what of future? | 07 Apr 08

Nature Publishing Group To Co-Publish Two Top-Quality International Journals Based In China| 04 Apr 08

House Committee Seeks Information On Marketing, 'Bundling' Contracts Related To Anemia Medications| 03 Apr 08

Boehringer's blood pressure drug cuts down cardiovascular risks| 02 Apr 08

Pediatric trials require more safety measures, study finds | 01 Apr 08

UH Chemist Earns Top Honor For Simplifying Manufacture Of Drugs, Plastics| 31 Mar 08

Sirtris Pharmaceuticals Presents At Future Leaders In The Biotechnology Industry Conference March 27| 27 Mar 08

GE Healthcare Launches Sterile Genderless Connector For Disposable Biopharmaceutical Production| 26 Mar 08

NuRx initiates dosing in Phase I cancer study | 25 Mar 08

Heparin Investigation - Latest Baxter Update| 20 Mar 08

GSK adopts differential pricing to boost sales| 18 Mar 08

Nitric BioTherapeutics Launches Phase II Clinical Trial For The Use Of Nitric Oxide In The Healing Of Chronic Wounds| 17 Mar 08

1-30 31-60 61-90 91-120 121-150 151-180 181-210 211-240 241-270 271-300 301-330 331-360 361-390 391-420 421-450 451-480 481-510 511-540 541-570 571-600 601-630 631-660 661-690 691-720 721-750 751-780 781-810 811-840 841-870 871-900 901-930 931-960 961-973